Objective:

To address the growing gap between liver transplant demand and available organs, particularly due to increasing wait times and disease progression, by establishing an adult living donor liver transplant program.

Approach:

Key Findings:

• The number of patients on the liver transplant waiting list is increasing, partly due to metabolic dysfunction-associated steatohepatitis (MASH), which has seen a significant rise in registrations.
• MASH accounted for 20.4% of liver transplant wait list registrations in 2023, highlighting the urgent need for expanded transplant options.
• Living donor transplantation can benefit patients with significant disease burden despite low MELD scores, offering a critical alternative for timely intervention.

Interpretation:

The establishment of the adult living donor program aims to provide timely transplants for patients at risk of disease progression, addressing the urgent need created by increasing wait times.

Limitations:

• Adult-to-adult living donor transplantation requires additional infrastructure and planning compared to pediatric settings, which may limit immediate scalability.
• The program is limited to specific conditions and patient populations identified for living donation, potentially restricting access for some patients.

Conclusion:

The program expands treatment options for patients with advanced liver disease in the Midwest, addressing a critical need in the region.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.